Citigroup Inc. (NYSE:C) has risen 35.60% since February 11, 2017 and is uptrending. It has outperformed by 75.15% the S&P500. Foresite Capital Management Ii Llc who had been investing in Epizyme Inc. for a number of months, seems to be bullish on the $1.11 billion market cap company. The stock increased 2.51% or $3.17 during the last trading session, reaching $129.53. Legal & General Group Plc raised its holdings in shares of Epizyme by 8.9% in the 1st quarter. Lowe's Companies, Inc. (NYSE:LOW) has risen 5.92% since February 10, 2017 and is uptrending. It has underperformed by 27.06% the S&P500.
Investors sentiment decreased to 1.46 in Q3 2017.
Among 13 analysts covering Epizyme (NASDAQ:EPZM), 12 have Buy rating, 0 Sell and 1 Hold. 115 funds opened positions while 384 raised stakes. 192.13 million shares or 2.08% less from 196.23 million shares in 2017Q2 were reported. (NYSE:NBL). Oslo Asset Management As invested 1.25% in Noble Energy, Inc. Cann reaffirmed a buy rating and set a $26.00 price objective on shares of Epizyme in a report on Tuesday, December 12th. Wells Fargo Communications Mn stated it has 0% of its portfolio in Epizyme, Inc. They expect $-0.57 EPS, up 5.00% or $0.03 from last year's $-0.6 per share. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.02% in AMETEK, Inc.
Among 23 analysts covering Dover (NYSE:DOV), 12 have Buy rating, 0 Sell and 11 Hold. Sumitomo Mitsui Asset Limited stated it has 102,200 shares. Northern Trust Corp reported 516,940 shares. Bingham Osborn And Scarborough Ltd invested in 0.03% or 3,010 shares. (NYSE:AME) for 461,786 shares. Royal National Bank Of Canada has 0% invested in Epizyme, Inc. Financial Bank Of America Corp De has invested 0% in Epizyme, Inc. Zacks Investment Research lowered Epizyme from a "hold" rating to a "sell" rating in a research report on Wednesday, January 3rd. Therefore 64% are positive. On Monday, October 31 the stock rating was downgraded by PiperJaffray to "Neutral". RBC Capital Markets maintained Lowe's Companies, Inc. The rating was initiated by Stifel Nicolaus on Tuesday, January 24 with "Buy". Finally, Leerink Swann restated an outperform rating and issued a $31.00 target price on shares of Epizyme in a research note on Friday, June 16th. Principal Financial Group Inc. grew its stake in shares of Epizyme by 1.5% in the 2nd quarter. The stock has "Buy" rating by S&P Research on Wednesday, October 14. Corporate insiders own 25.20% of the company's stock. The rating was maintained by Barclays Capital on Monday, November 6 with "Overweight". The firm has "Buy" rating given on Wednesday, June 7 by Cowen & Co.
Valicenti Advisory Services Inc, which manages about $376.66 million and $198.76 million US Long portfolio, decreased its stake in Zoetis Inc (NYSE:ZTS) by 6,074 shares to 79,377 shares, valued at $5.06M in 2017Q3, according to the filing.
Since September 19, 2017, it had 0 insider purchases, and 2 sales for $778,532 activity. Shares for $614,857 were sold by Hollifield Matthew V. 200,000 shares valued at $3.05 million were bought by MOTT DAVID M on Monday, September 18. Piper Jaffray maintained Noble Energy, Inc. (NASDAQ:EPZM) for 110,012 shares. Jefferies Group also issued estimates for Epizyme's Q4 2017 earnings at ($0.55) EPS, Q1 2018 earnings at ($0.55) EPS, Q2 2018 earnings at ($0.57) EPS, Q3 2018 earnings at ($0.67) EPS, Q4 2018 earnings at ($0.62) EPS, FY2018 earnings at ($2.41) EPS and FY2019 earnings at ($2.37) EPS. Its up 0.21, from 0.99 in 2017Q2. It worsened, as 15 investors sold Epizyme, Inc. shares while 22 reduced holdings. Virtus Fund Advisers LLC acquired a new position in shares of Epizyme in the fourth quarter worth about $346,000. Renaissance Tech Lc holds 0.01% or 230,388 shares. 46,600 were accumulated by State Common Retirement Fund. Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 988 shares. California Public Employees Retirement System grew its stake in shares of Epizyme by 2.2% in the 2nd quarter. (NASDAQ:EPZM). Rhumbline Advisers reported 50,620 shares stake. Trexquant Ltd Partnership owns 28,593 shares or 0.14% of their United States portfolio. 3,242 are held by Ameritas Inv Ptnrs. (NYSE:AME). Polar Asset Mgmt Ptnrs holds 0.36% or 271,500 shares. Aqr Cap Ltd Liability Co, Connecticut-based fund reported 32,692 shares. 64,789 are owned by Credit Suisse Ag.
Epizyme (NASDAQ EPZM) opened at 16.95 on Tuesday. (NASDAQ:EPZM) for 13,390 shares. Invesco Ltd has 405,513 shares. Pacad Invest Ltd accumulated 4,000 shares or 0.02% of the stock. First Personal Fincl Svcs holds 3,265 shares or 0.05% of its portfolio. Two analysts have rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. Therefore 100% are positive. AMETEK had 59 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by Oppenheimer with "Buy" on Monday, July 24. (NYSE:NBL) earned "Buy" rating by RBC Capital Markets on Thursday, June 1. (NASDAQ:EPZM) to report earnings on March, 8. The firm earned "Buy" rating on Thursday, January 18 by Wells Fargo. On Tuesday, May 10 the stock rating was maintained by Mizuho with "Buy". (TSE:ECI) on Friday, July 15 with "Buy" rating. The stock of Dover Corporation (NYSE:DOV) has "Hold" rating given on Friday, October 20 by SunTrust. Oppenheimer maintained it with "Buy" rating and $2600 target in Wednesday, June 14 report. The firm has "Buy" rating given on Thursday, August 6 by Mizuho.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.